A Double Dose of Reality: A Look Back at What Went Wrong at KV Pharma

The saga of KV Pharmaceutical provides a cautionary tale for any manufacturer who would overlook manufacturing quality issues and attempt to fly under the regulatory radar. As most in the industry know, KV has gone from a model growth company to one on the brink of bankruptcy, following manufacturing issues which included the production of oversized tablets (some of which contained double doses of API), and then subsequent attempts to falsify records and cover up the problems. 

The St. Louis Post-Dispatch has just published an excellent summary of what happened at KV, and what issues the manufacturer faces as it tries to stay afloat.




Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


  • <p><a href="http://www.brain-dump.us/N10-004.html">N10-004 braindumps</a> | <a href="http://www.brain-dump.us/70-642.html">70-642 braindumps</a> | <a href="http://www.brain-dump.us/640-801.html">640-801 braindumps</a> | <a href="http://www.brain-dump.us/640-822.html">640-822 braindumps</a> | <a href="http://www.brain-dump.us/350-001.html">350-001 braindumps</a> | <a href="http://www.brain-dump.us/70-647.html">70-647 braindumps</a> | <a href="http://www.brain-dump.us/PMI-001.html">PMI-001 braindumps</a> | <a href="http://www.brain-dump.us/220-701.html">220-701 braindumps</a> |</p> <p>Loved to read your blog. I would like to suggest you that traffic show most people read blogs on Mondays. So it should encourage blogger to write new write ups over the weekend primarily. </p>


RSS feed for comments on this page | RSS feed for all comments